GSK plc ADR buy Citigroup Inc.
Start price
13.02.24
/
50%
€38.80
Target price
13.02.25
-
Performance (%)
-6.00%
Price
22:26
€35.40
Summary
This prediction is currently active. With a performance of -6.00%, the BUY prediction for GSK plc ADR by Citigroup_Inc_ is down slightly. Dividends of €1.07 are taken into consideration when calculating the performance. This prediction currently runs until 13.02.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
GSK plc ADR | -4.372% | -4.372% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by Citigroup_Inc_ for this prediction
In the thread GSK plc ADR diskutieren
GSK plc (NYSE: GSK) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Ratings data for GSK provided by MarketBeat